N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.10p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.30
  • 52 Week Low: 0.43
  • Currency: UK Pounds
  • Shares Issued: 101.46m
  • Volume: 90,573
  • Market Cap: £3.15m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
89.32% below the market average89.32% below the market average89.32% below the market average89.32% below the market average89.32% below the market average
73.68% below the sector average73.68% below the sector average73.68% below the sector average73.68% below the sector average73.68% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
73.41% above the market average73.41% above the market average73.41% above the market average73.41% above the market average73.41% above the market average
58.82% above the sector average58.82% above the sector average58.82% above the sector average58.82% above the sector average58.82% above the sector average
Price Book Ratio
62.98% below the market average62.98% below the market average62.98% below the market average62.98% below the market average62.98% below the market average
5.26% below the sector average5.26% below the sector average5.26% below the sector average5.26% below the sector average5.26% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
1.64% below the market average1.64% below the market average1.64% below the market average1.64% below the market average1.64% below the market average
8.47% above the sector average8.47% above the sector average8.47% above the sector average8.47% above the sector average8.47% above the sector average
Price Chg 3m
19.77% below the market average19.77% below the market average19.77% below the market average19.77% below the market average19.77% below the market average
11.86% above the sector average11.86% above the sector average11.86% above the sector average11.86% above the sector average11.86% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI Not Available
Momentum 20 Not Available

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
94.77% below the market average94.77% below the market average94.77% below the market average94.77% below the market average94.77% below the market average
65% below the sector average65% below the sector average65% below the sector average65% below the sector average65% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
58.09% below the market average58.09% below the market average58.09% below the market average58.09% below the market average58.09% below the market average
1.69% above the sector average1.69% above the sector average1.69% above the sector average1.69% above the sector average1.69% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
94.05% below the market average94.05% below the market average94.05% below the market average94.05% below the market average94.05% below the market average
80% below the sector average80% below the sector average80% below the sector average80% below the sector average80% below the sector average
Operating Profit Loss
50.73% below the market average50.73% below the market average50.73% below the market average50.73% below the market average50.73% below the market average
28.81% above the sector average28.81% above the sector average28.81% above the sector average28.81% above the sector average28.81% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets Not Available
Cash
69.14% below the market average69.14% below the market average69.14% below the market average69.14% below the market average69.14% below the market average
86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average86.21% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
47.46% below the market average47.46% below the market average47.46% below the market average47.46% below the market average47.46% below the market average
61.11% below the sector average61.11% below the sector average61.11% below the sector average61.11% below the sector average61.11% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

N4 Pharma Market Data

Currency UK Pounds
Share Price 3.10p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.30
52 Week Low 0.43
Volume 90,573
Shares Issued 101.46m
Market Cap £3.15m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
37.1% below the market average37.1% below the market average37.1% below the market average37.1% below the market average37.1% below the market average
66.1% below the sector average66.1% below the sector average66.1% below the sector average66.1% below the sector average66.1% below the sector average
Value
37.1% below the market average37.1% below the market average37.1% below the market average37.1% below the market average37.1% below the market average
66.1% below the sector average66.1% below the sector average66.1% below the sector average66.1% below the sector average66.1% below the sector average
Income Not Available
Growth
25.14% below the market average25.14% below the market average25.14% below the market average25.14% below the market average25.14% below the market average
26.32% below the sector average26.32% below the sector average26.32% below the sector average26.32% below the sector average26.32% below the sector average

N4 Pharma Dividends

No dividends found

Trades for 06-Dec-2019

Time Volume / Share Price
09:24 5,000 @ 3.30p
08:30 34,900 @ 2.97p
08:28 18,345 @ 3.00p
08:11 32,328 @ 3.12p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page